group B streptococcal vaccine (LigoCyte)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug Namegroup B streptococcal vaccine (LigoCyte)
Drug Alias NameStreptococcus group B vaccine (LigoCyte)MC-L21
ClassificationVaccines > Application > Therapeutic vaccine
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsStreptococcus group B infectionSepsis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesTakeda Vaccines Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesTakeda Vaccines Inc
Active IndicationsN/A
Inactive IndicationsStreptococcus group B infectionSepsis

Other Information

ATC CodeN/A
Related LinksN/A